Journal Articles
2019

Correlates of genetic attributions among parents of children in the
USA with developmental disabilities
B. Kiely
S. Vettam
A. Adesman
Zucker School of Medicine at Hofstra/Northwell, aadesman@northwell.edu

Follow this and additional works at: https://academicworks.medicine.hofstra.edu/articles
Part of the Pediatrics Commons

Recommended Citation
Kiely B, Vettam S, Adesman A. Correlates of genetic attributions among parents of children in the USA
with developmental disabilities. . 2019 Jan 01; 12():Article 5665 [ p.]. Available from:
https://academicworks.medicine.hofstra.edu/articles/5665. Free full text article.

This Article is brought to you for free and open access by Donald and Barbara Zucker School of Medicine Academic
Works. It has been accepted for inclusion in Journal Articles by an authorized administrator of Donald and Barbara
Zucker School of Medicine Academic Works. For more information, please contact academicworks@hofstra.edu.

The Application of Clinical Genetics

Dovepress
open access to scientific and medical research

ORIGINAL RESEARCH

Open Access Full Text Article

Correlates of genetic attributions among parents
of children in the USA with developmental
disabilities

Bridget Kiely
Sujit Vettam
Andrew Adesman
Division of Developmental and
Behavioral Pediatrics, Department
of Pediatrics, Steven and Alexandra
Cohen Children’s Medical Center of
New York, New Hyde Park, NY, USA

Introduction: As technologies for identifying causal genetic variants in children with autism
spectrum disorders (ASD) and other developmental conditions continue to advance, there is a
need to understand the factors that influence parental beliefs about the causes of their child’s
disabilities. This study assessed the correlates of etiologic attributions among US parents of
children with ASD, intellectual disability (ID), and/or developmental delay (DD).
Methods: Data were obtained from the Centers for Disease Control and Prevention’s nationally representative Survey of Pathways to Diagnosis and Services. Respondents were classified
according to whether their child had ASD without ID or DD (ASD-only), ASD with ID and/or
DD (ASD+ID/DD), or ID and/or DD without ASD (ID/DD-only). Respondents rated the extent
to which they believed that genetics/heredity and environmental exposures (prenatal and/or
postnatal) had contributed to their child’s condition. Logistic regression analyses and chi-square
tests were used to assess the relationship between parental beliefs and child characteristics.
Results: The parents of children with comorbid ASD and ID/DD were found to be significantly
less likely than those in the other condition groups to attribute their child’s condition to genetics.
Within the ASD+ID/DD group, parental endorsement of genetics was lower among those who
reported a history of language regression (p=0.006).
Conclusion: Further research is needed to evaluate the impact of parental genetic attributions
on medical decision-making.
Keywords: parental beliefs, etiology, developmental disabilities, autism spectrum disorders,
intellectual disability
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The rising prevalence of autism spectrum disorders (ASD) in the USA has fueled
scientific and popular interest in the causes of this condition.1 As a growing body of
research continues to reveal the genetic heterogeneity underlying the autism spectrum,
clinical genetics professionals are likely to play an increasingly important role in the
medical assessment of affected children.2,3 In recognition of the potential benefits of
obtaining a genetic diagnosis, the American College of Medical Genetics and Genomics
has recommended that genetic testing be offered to all children with ASD.4 However,
genetics services remain underutilized in this population, and recent studies suggest
that less than half of all children with ASD undergo recommended genetic testing.5,6
Barriers to the utilization of genetics services in this population include limited parental
awareness of genetic testing options, concerns about cost, and uncertainty about the
value of a genetic diagnosis.6,7
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Although clinicians play a vital role in facilitating access
to genetics services for children with ASD, decisions about
whether to pursue genetic testing ultimately rest with the parents themselves, who may act on physician recommendations
and interpret the results of genetic testing in the context of
their existing beliefs about ASD etiology.7,8 Studies of parental etiological attributions have produced varying estimates
of the proportion of parents that believe their child’s ASD has
a genetic basis; a 2006 survey of 41 parents found that more
than 90% believed that genetic influences had contributed to
their child’s ASD, while another study from the same year
reported that just 26% of their 62-parent sample endorsed
genetic predisposition as a cause.9,10 These studies have also
documented the wide range of nongenetic causes to which
parents commonly attribute their child’s ASD, including
prenatal exposures, perinatal events, vaccinations, dietary
sensitivities, child illnesses, parental age, environmental
toxins, and other factors.9–13
In addition to influencing their utilization of genetics services, parental etiological attributions may shape a range of
other medical decisions. A survey-based study of more than
250 parents of children with ASD concluded that parental
perceptions of recurrence risk frequently affected family
planning decisions, especially among those who perceived
their recurrence risk to be high.11 Likewise, population-based
studies have found evidence that families commonly engage
in “reproductive stoppage” after a child is diagnosed with
ASD.14 Etiological attributions to nongenetic factors may
also influence treatment decisions; concerns about a causal
relationship between vaccines and ASD have commonly
been given as a reason for vaccine refusal, which has been
linked to recent measles outbreaks in the USA.15–17 Parental
endorsement of food allergies as a cause of ASD has also
been associated with use of chelation, a controversial intervention that lacks demonstrated efficacy and carries a risk
of death.12,18
Collectively, these findings highlight the clinical relevance of parental etiological attributions and underscore
the need for research aimed at understanding the factors that
influence these beliefs. Studies of cross-cultural variation in
ASD perceptions have identified numerous factors – including social norms and religious or spiritual beliefs – that may
contribute to cultural differences in parental appraisal of ASD
symptoms.19,20 In addition, parental etiological beliefs about
ASD have been shown to differ according to ethnicity, family
structure, and income in the USA.21 However, it is not known
to what extent differences in child clinical presentation may
contribute to variation in parental beliefs about ASD etiology.
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The autism spectrum is highly heterogeneous with respect
to symptom severity and cognitive functioning, encompassing nonverbal children with severe intellectual impairments
along with those who test in the superior range on measures
of cognitive ability. Several lines of evidence suggest that,
compared to children with either condition alone, children
with ASD and co-occurring cognitive impairment present
with a distinct clinical profile that includes an earlier age
of parent-reported onset and an increased risk for comorbid
psychopathology and challenging behaviors.22–24 Given the
potential for parental etiological attributions to be influenced
by these factors, the aim of the present study was to compare
the causal beliefs held by the parents of children with ASD
and comorbid intellectual disability (ID) and/or developmental delay (DD) to those held by the parents of children
with either ASD or ID/DD alone. A better understanding
of the determinants of parental beliefs about ASD etiology
may facilitate improved communication between genetics
professionals and affected families.

Methods
Data were analyzed from the 2011 Survey of Pathways to
Diagnosis and Services (“Pathways”). The Pathways survey was conducted by the Centers for Disease Control and
Prevention (CDC) through the National Center for Health
Statistics, State and Local Area Integrated Telephone Survey
program. This survey was a follow-up to the 2009–2010
National Survey of Children with Special Health Care Needs
(NS-CSHCN), a cross-sectional, random-digit-dial telephone
survey of the parents and guardians of US children with special health care needs (CSHCN) between the ages of 0 and 17.
A random sample of 6,090 NS-CSHCN respondents who had
previously indicated that their child had ever been diagnosed
with ASD, ID, and/or DD were selected to be recontacted for
the Pathways survey. Those who were successfully contacted
were further screened to confirm that the eligible child was
between the ages of 6 and 17 at the time of the interview,
continued to live with the respondent, and had been diagnosed
with one of the abovementioned developmental conditions.
The Pathways interview was completed by 4,032 respondents.
Weighted estimates derived from the Pathways dataset are
representative of the US population of noninstitutionalized
CSHCN who have ever been diagnosed with ASD, ID, and/or
DD. As a secondary analysis of publicly available, deidentified data, this study was exempt from Institutional Review
Board approval.
The present analysis was limited to respondents who
indicated that their child had ASD, ID, and/or DD at the
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time of the Pathways interview, based on three questions
about whether, to the best of the respondent’s knowledge, the
child currently had “autism or an autism spectrum disorder,”
“an intellectual disability or mental retardation,” and/or
“a developmental delay that affected his/her ability to learn.”
Respondents who met these criteria were further classified
into three condition groups: 1) those whose children currently
had ASD, without ID or DD (“ASD-only” n=492); 2) ASD
with ID and/or DD (“ASD+ID/DD” n=913); or 3) ID and/
or DD, without ASD (“ID/DD-only” n=1,949). Pathways
respondents who had previously indicated that their child
had Down syndrome were excluded.
Parental beliefs about the etiology of their child’s developmental disabilities were assessed based on three questions.
Respondents were asked whether they thought that their
child’s condition was 1) “genetic or hereditary”; 2) “caused
by something he/she was exposed to in utero, that is, before
he/she was born”; and 3) “caused by something he/she was
exposed to after he/she was born.” These questions were
adapted from the Revised Illness-Perception Questionnaire
modified for autism (IPQ-RA). A scale was used for each
question, with possible responses of “definitely agree,”
“somewhat agree,” “somewhat disagree,” and “definitely
disagree.” Respondents were also permitted to answer “don’t
know” to each question. In the present analysis, responses
were dichotomized into those who endorsed (answered
“definitely agree” or “somewhat agree”) or did not endorse
(answered “definitely disagree,” “somewhat disagree,” or
“don’t know”) each of the three causes.
The proportion of respondents that endorsed each of the
three etiologic categories (genetics, prenatal environmental
exposures, and postnatal environmental exposures) was calculated separately for the ASD-only, ASD+ID/DD, and ID/
DD-only groups. Multivariable logistic regression analyses
were used to compare beliefs between groups. Age, sex, race,
ethnicity, household income, and household education level
were included in the models to control for the potentially
confounding effects of these demographic characteristics.
Respondents were further classified based on the combination of responses they provided to the three etiology
questions: 1) those who endorsed genetics but did not endorse
prenatal or postnatal exposures (hereafter referred to as
“predominantly genetic”); 2) those who endorsed prenatal
and/or postnatal exposures but did not endorse genetics
(“predominantly environmental”); 3) those who endorsed
genetics plus prenatal and/or postnatal exposures (“genetic
and environmental”); and 4) those who endorsed neither
genetics nor environmental exposures (“neither”). Multivari-
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able logistic regression analyses were used to compare the
prevalence of each of these response patterns across the three
groups (ASD-only, ASD+ID/DD, and ID/DD-only). All models controlled for demographic characteristics (age, sex, race,
ethnicity, household income, household education level).
Further analyses were performed to assess the association
between parental beliefs and the child’s developmental characteristics. Information about the child’s history of regression
was obtained through a question about whether, at the time
that the parent’s concerns began, they felt that some of the
child’s “speech skills that he/she had already developed were
lost.” This question was only asked of parents who reported
that the child’s age at the onset of their concerns was at least 9
months. Rao–Scott χ2 tests were used to compare the proportion of respondents that endorsed each of the three etiologic
categories (between those who did and did not report a history
of language regression).

Results
Across all groups, a majority of respondents – including 72%
of the ASD-only group, 57% of the ASD+ID/DD group, and
67% of the ID/DD-only group – identified genetic or hereditary
factors as a cause of their child’s condition (Table 1). By contrast, a minority of respondents in each group endorsed prenatal
(28%–33%) or postnatal (25%–40%; Table 1) environmental
exposures. Logistic regression analyses showed that, after
adjusting for demographic factors, respondents in the ASD+ID/
DD group were significantly less likely than those in the ASDonly and ID/DD-only groups to attribute their child’s condition
to genetics/heredity (adjusted odds ratio [aOR] =0.6 for both;
Table 2). Although endorsement of postnatal exposures did
not differ between the two ASD groups, respondents in both
were significantly more likely than those in the ID/DD-only
group to attribute their child’s condition to exposures after
birth; just 25% of the I D/DD-only group (Table 1) endorsed
postnatal exposures, compared to 34% of the ASD-only group
(aOR =1.7; Table 2) and 40% of the ASD+ID/DD group (aOR
=2.0). Parental endorsement of prenatal exposures did not differ between condition groups (Table 2).
Similar patterns emerged when respondents were classified according to the combination of responses that they
provided to the three etiologic questions in the Pathways
survey. Although a significant proportion of respondents in
each group attributed their child’s condition to both genetic
factors and environmental exposures (29%–32%; Table 1),
many appeared to favor one over the other, endorsing
either genetics/heredity but not environmental exposures
(“predominantly genetic”), or exposures but not genetics/
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Table 1 Prevalence of etiological attributions by condition group
Condition
group

Genetic

Environmental

Any genetic
(%)

Predominantly
genetic
(%)

Any prenatal
exposure
(%)

Any postnatal
exposure
(%)

ASD+ID/DD
ASD-only
ID/DD-only

56.8±2.9
71.8±3.7
66.5±2.1

25.3±2.4
40.7±4.1
37.4±2.2

33.0±2.7
28.1±3.9
31.6±2.0

39.8±2.9
33.9±3.9
24.6±2.1

Predominantly
environmental
(%)

Both
genetic and
environmental
(%)

Neither
(%)

25.4±2.5
15.4±3.1
15.8±1.4

31.5±2.8
31.0±3.7
28.7±2.2

17.6±2.2
12.8±2.6
17.6±1.9

Notes: Respondents were asked to indicate the extent to which they believed that genetics/heredity, prenatal exposures, and postnatal exposures had contributed to
their child’s condition. The “Any genetic” column shows the proportion of respondents that endorsed (answered “definitely” or “somewhat” agree) genetics/heredity;
“Predominantly genetic” column shows the proportion that endorsed genetics but not environmental exposures; “Any prenatal” and “Any postnatal” columns show
the proportion that endorsed prenatal exposures and postnatal exposures, respectively; “Predominantly environmental” column shows the proportion that endorsed
environmental exposures but not genetics; “Both” column shows the proportion that endorsed genetics and environmental exposures; “Neither” column shows the
proportion that did not endorse any of the three causes.
Abbreviations: ASD, autism spectrum disorders; DD, developmental delay; ID, intellectual disability.

Table 2 Comparison of etiological attributions by condition group
Condition
group

Genetic

Environmental

Neither

Predominantly
environmental
aOR (95% CI)

Both
genetic and
environmental
aOR (95% CI)

Any genetic
aOR (95% CI)

Predominantly
genetic
aOR (95% CI)

Any prenatal
exposure
aOR (95% CI)

Any postnatal
exposure
aOR (95% CI)

ASD+ID/DD vs
ASD-only
ASD+ID/DD vs
ID/DD-only
ASD-only
vs
ID/DD-only

0.6 (0.4–0.9)*

0.5 (0.3–0.8)*

1.3 (0.8–2.0)

1.2 (0.8–1.9)

1.8 (1.0–3.1)*

1.1 (0.7–1.7)

1.4 (0.8–2.5)

0.6 (0.5–0.9)*

0.5 (0.4–0.7)*

1.1 (0.8–1.5)

2.0 (1.4–3.0)*

1.7 (1.2–2.5)*

1.2 (0.8–1.8)

1.1 (0.7–1.7)

1.2 (0.8–1.8)

1.0 (0.7–1.5)

0.9 (0.5–1.3)

1.7 (1.1–2.6)*

1.0 (0.6–1.7)

1.1 (0.7–1.7)

0.8 (0.5–1.4)

Notes: Respondents were asked to indicate the extent to which they believed that genetics/heredity, prenatal exposures, and postnatal exposures had contributed to their
child’s condition. Parental endorsement of genetics/heredity, prenatal exposures, and postnatal exposures were compared across groups. Multivariable logistic regression
analyses controlled for age, sex, race, ethnicity, household income level, and household education level. *Significance, set at the p<0.05 level.
Abbreviations: aOR, adjusted odds ratio; ASD, autism spectrum disorders; CI, confidence interval; DD, developmental delay; ID, intellectual disability.

heredity (“predominantly environmental”). However, the
distribution of respondents between the “predominantly
genetic” and “predominantly environmental” response
categories differed among the three condition groups. In
the ASD-only and ID/DD-only groups, the “predominantly
genetic” response pattern was more common (ASD-only:
41%; ID/DD-only: 37%; Table 1) than the “predominantly
environmental” one (ASD-only: 15%; ID/DD-only: 16%). In
the ASD+ID/DD group, by contrast, respondents were more
evenly split, with roughly equal percentages of respondents
falling into the “predominantly genetic” and “predominantly
environmental” categories (25% each; Table 1). Multivariable logistic regression analyses showed that, compared to
those in either of the other condition groups, respondents in
the ASD+ID/DD group were significantly less likely to hold
“predominantly genetic” beliefs (ASD-only: aOR=0.5; ID/
DD-only: aOR=0.5; Table 2) and significantly more likely
to hold “predominantly environmental” beliefs (ASD-only:
aOR=1.8; ID/DD-only: aOR=1.7).
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Within each group, Rao–Scott χ2 tests were performed
to examine the relationship between parental beliefs and
parent report of language regression. In the ASD-only and
ID/DD-only groups, no associations were identified between
regression history and parental beliefs (Table 3). However, in
the ASD+ID/DD group, respondents who reported that their
child had a history of regression were significantly less likely
to endorse genetics (p=0.006) and significantly more likely
to endorse postnatal exposures (p<0.001) as contributors to
their child’s developmental disabilities, compared to those
who reported no history of regression (Table 3).

Discussion
Numerous studies have documented the wide range of genetic
and nongenetic factors to which parents commonly attribute
their child’s ASD. Although the diversity in these etiological
explanations rivals the heterogeneity of the autism spectrum
itself, little is known about the factors that influence these
beliefs, and it is unclear whether parental etiological attri-
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Table 3 Association between history of language regression and parental beliefs
Condition
group

Genetic
Reg. (%)

Non-reg. (%)

p-value

Reg. (%)

Non-reg. (%)

p-value

Reg. (%)

Non-reg. (%)

p-value

ASD-only

63.2±9.0
48.2±5.0
71.8±4.0

72.9±4.5
66.6±4.1
69.5±3.0

0.317
0.006*
0.649

34.1±9.1
32.3±4.8
31.8±4.2

17.4±3.9
31.6±4.0
31.1±2.8

0.065
0.907
0.897

45.5±10.1
51.2±5.0
23.8±3.6

26.4±4.2
28.9±3.8
22.8±2.5

0.070

ASD+ID/DD
ID/DD-only

Prenatal

Postnatal

<0.001*
0.816

Notes: Within each condition group, χ2 tests were used to compare rates of endorsement of each etiologic category (genetics, prenatal exposures, postnatal exposures)
between respondents who reported that their child had a history of language regression and those who reported no regression. *Significance, set at the p<0.05 level.
Abbreviations: ASD, autism spectrum disorders; DD, developmental delay; ID, intellectual disability; reg, regression; non-reg, no regression.

butions differ according to the child’s cognitive status. The
aim of the present study was to use data from a nationally
representative sample of more than 3,000 respondents to
compare the etiologic beliefs held by the parents of children
with ASD and comorbid ID and/or DD (ASD+ID/DD) to
those held by the parents of children with either condition
alone (ASD-only or ID/DD-only).
A majority of respondents in the Pathways sample
believed that their child’s condition had a genetic or hereditary basis. Among the parents of children with ASD, the
proportion of respondents that endorsed genetics/heredity
was 57% for the ASD+ID/DD group and 72% for the ASDonly group. Additionally, more than one-fourth (29%–32%)
of each condition group attributed their child’s condition to
both genetics and environmental (prenatal and/or postnatal)
exposures. These estimates are reasonably consistent with
the findings of a 2009 study that reported that 73% of their
sample attributed their child’s ASD to genetic influences.11
However, the results of the present analysis diverge from
the findings of a number of other studies, including one that
reported that just 26% of respondents believed that their
child’s ASD had a genetic basis.10 These discrepancies may
be due in part to differences in respondent characteristics;
whereas the prior studies utilized relatively small convenience
samples, the Pathways study was designed to be nationally
representative.
When the three condition groups were compared, the
parents of children with ASD and comorbid intellectual/DDs
showed a greater tendency to attribute their child’s condition
to nongenetic factors than the parents of children with either
condition alone. After controlling for demographic factors,
parents in the ASD+ID/DD group were significantly less
likely to attribute their child’s condition to genetics/heredity
than those in either the ASD-only or ID/DD-only groups.
Moreover, when respondents were classified according to the
combination of responses they provided to the three etiology
questions in the Pathways survey, those in the ASD+ID/DD
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group were significantly more likely to hold “predominantly
environmental” beliefs, and less likely to hold “predominantly genetic” beliefs, than their counterparts in the other
condition groups.
Additional analyses identified a subset of respondents in
the ASD+ID/DD group that were especially likely to subscribe to nongenetic, external explanations for their child’s
disabilities. Among the parents of children with ASD+ID/DD,
those who reported that their child had a history of language
regression were significantly more likely to endorse postnatal
exposures as a contributor to their child’s condition, and less
likely to endorse genetics, than those who indicated that their
child had not regressed. These findings are consistent with
the results of a 2005 survey that compared etiologic beliefs
between parents who reported that their child had always
had symptoms of ASD (“congenital”) and those who indicated that their child had regressed after a period of normal
development (“regressive”).25 In that study, parents in the
“congenital” group were more likely to view their child’s
condition as genetic, whereas those in the “regressive” group
were more likely to attribute their child’s ASD to external factors. Although the Pathways survey did not directly assess the
extent to which beliefs influenced parental decision-making
in this sample, a number of controversial practices for preventing or treating ASD – such as chelation, withholding of
immunizations, antibiotics, antiviral agents, and high-dose
vitamins – are predicated on the belief that external factors
can trigger or worsen the symptoms of ASD. Thus, future
studies should aim to characterize the relationship between
parental etiological attributions and use of these alternative
therapies.
Although the use of the large, nationally representative
Pathways sample was a major strength of the present analysis,
the survey-based design of this study was also associated
with a few limitations. The Pathways interview asked parents
to rate the extent to which they believed that three broad
categories of etiologic factors (genetics/heredity, prenatal

submit your manuscript | www.dovepress.com

Dovepress

59

Dovepress

Kiely et al

exposures, and postnatal exposures) had contributed to their
child’s condition. A drawback of this format is that it did not
permit assessment of the prevalence of specific etiologic
attributions. Parents who endorsed postnatal exposures, for
example, may have attributed their child’s condition to factors
as diverse as vaccines, heavy metals, infections, medications,
or other substances. The format of this survey also precluded
assessment of etiologic beliefs that did not fall into any of
the three categories encompassed by the Pathways questions.
Notably, 13%–18% of each group analyzed in this study did
not endorse any of the three etiologic categories. Previous
studies based on open-ended questions have identified a number of parental etiologic attributions that were not addressed
in the Pathways survey, including religious or superstitious
factors, parental age, and other causes.20
Another limitation of the present study is that the Pathways survey relied on parent-reported diagnoses that were
not independently verified. Recent records-based epidemiological studies conducted by the CDC have estimated that
31%–41% of children with ASD have an IQ consistent with
ID (≤70), with an additional 21%–24% falling in the “Borderline” (71–85) range.26–28 By contrast, just 21% of children
with ASD in the Pathways sample were reported to have ID,
while 44% were reported to have ASD+DD without ID. This
suggests that ID may have been underreported in this sample,
and that some of the children who were identified as having
ASD+DD may have had cognitive impairment consistent
with ID even if the parents reported otherwise. Thus, the
present study grouped children with ASD-only separately
from those with ASD plus ID and/or DD (ASD+ID/DD) to
preserve the distinction between children with normal intellectual functioning and those with some degree of cognitive
impairment. This c lassification is supported by the fact
that, among children with ASD in the Pathways sample, the
prevalence of comorbid ID and/or DD (65%) roughly corresponds to the total percent of children in the records-based
epidemiological studies (54%–62%) that tested below the
average range on measures of IQ (≤85).26–28 However, the
ASD+ID/DD group was likely clinically heterogeneous, and
the inability to corroborate parent-reported diagnoses with
validated measures of functioning represents a significant
limitation of the present study.

Conclusion
Notwithstanding the limitations discussed above, the findings of this study are highly relevant to clinicians who
provide care to children with developmental disabilities
and their families. Genetics professionals, in combination
with other clinicians involved in the diagnostic process
60
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– including psychiatrists, developmental pediatricians,
neurologists, and primary care providers – play a vital role
in educating parents about etiology and helping them to
access recommended genetics services for their children.
This study showed that the parents of children with ASD
and comorbid ID/DD were significantly less likely than the
parents of children with either condition alone to attribute
their child’s condition to genetic or h ereditary factors,
especially if the child had a history of language regression.
Given that parental etiological attributions may influence
their utilization of numerous services for their children,
including genetic testing, an awareness of the factors that
influence parental etiological beliefs may allow clinicians
to provide more individualized counseling to affected
families. Overall, it is hoped that a better understanding of
the determinants and consequences of parental etiological
beliefs will facilitate improved access to genetics services
in this population.
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